- Injective price V-shaped recovery has seen it overcome the 50-day SMA at $36.39.
- INJ could extend the climb 20% to collect sell-side liquidity with technicals and on-chain metrics in support.
- The bullish thesis will be invalidated upon a break and close below $34.09.
Injective (INJ) price is in a recovery mode after a steep rejection from the $43.51 blockade that sent the AI crypto coin down nearly 30%. This time, however, the climb is steered by bullish technical as well as on-chain fundamentals, increasing the upside potential for INJ.
Also Read: Injective Price Prediction: Volan Mainnet Upgrade fails to catalyze recovery after 20% slump
Injective price eyes 15% gains
Injective (INJ) price could rise 15% to tag the $43.51 resistance level, with technical indicators flashing bullish. For one, the 50-, 100-, and 200-day Simple Moving Averages (SMAs) provide downward support at $36.39, $26.13, and $16.88 levels respectively, while pointing north to show this is the path with the least resistance.
The Relative Strength Index (RSI) is also inclined north, suggesting rising momentum after calling a signal to buy INJ when it crossed above the signal line. Traders heeding this call would enhance the climb for Injective price.
Further, the Moving Average Convergence Divergence (MACD) indicator is also teasing with a bullish crossover, accentuated by green histogram bars on the Awesome Oscillator. These add credence to the bullish thesis.
Enhanced buying pressure among the bulls could see Injective price make the 15% climb to the $43.51 barricade. In a highly bullish case, the gains could extend for the price to reclaim the range high at $45.30, potentially clearing as it reaches for the $50.00 psychological level.
INJ/USDT 1-day chart
On-chain metrics supporting bullish outlook for Injective price
On-chain metrics from Santiment support the bullish thesis. To start with, the social dominance of the AI crypto coin is rising, representing more levels of mentions of the INJ token across a pool of crypto-related social media.
INJ Santiment: Social dominance
There is also a significant rise in exchange outflow, reducing the effective short-term sell pressure on Injective price. This is accentuated by the supply on exchanges as a percentage of total supply, which appears subdued, moving horizontally at $-0.76 to show reducing sell pressure.
INJ Santiment: Exchange outflow, Supply on exchanges
On the other hand, if traders give in to their profit appetite and prematurely cash in on the gains made, Injective price could pull south, slipping below the 50-day SMA to retest the $34.00 support. A break and close below this level would invalidate the bullish thesis, with Injective price likely to extend the fall to the $31.00 psychological level.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended Content
Editors’ Picks
Crypto Today: Bitcoin crumbles under German government transfers, Ethereum and Ripple erase gains
Bitcoin trades below $57,100 on Thursday as German government transfers continue, $76 million BTC moved to exchanges. Ethereum trades near $3,100 ahead of the upcoming SEC decision on the Spot Ethereum ETF.
Ripple traders take over $75 million in losses in July, XRP drops below key support
Ripple (XRP) price is under fresh selling pressure and tests key support at the June 7 low of $0.4508 on Thursday as whales are likely capitulating, according to on-chain data.
Bitcoin price declines as supply on exchanges rises
Bitcoin faced rejection at the daily resistance level of $63,956 on Monday, resulting in a 4.2% decline over the next two days. BTC’s price extends its downward move and falls below $58,000 on Thursday, adding more than 4% losses in the day.
Worldcoin is poised for 17% rally as as technical indicators signal bullish momentum
Worldcoin price finds support and bounces 9% from the weekly support level around $2.183. Technical analysis shows that WLD has formed a bullish divergence on a momentum indicator.
Bitcoin: BTC price correction could end in July, according to seasonal data
Bitcoin (BTC) price appears poised for a decline this week, influenced by slight outflows in US spot ETFs, selling activity among BTC miners, and a combined transfer of 4,690.28 BTC to centralized exchanges by the US and German governments.